First, I doubt the company will be around by the beginning of 2023. But assuming it is and NWBO is actually listed on a major exchange, I would target $15 a share. But a lot has to happen in the interim of course.
PM question, do you expect NWBO to be acquired with FDA approval pending (BLA submitted but no answer back yet)?
Because even if we will see TLD + publication this month I do not see the BLA submitted until this fall, and I therefore do not see FDA approval between now and the beginning of 2023. I love for it to be different, but it would take a small miracle in velocity something NWBO has proven to be no good in.